Funded Biomarker Testing

Find an overview of funded biomarker testing in Ontario. Information listed includes diagnostic, predictive and prognostic markers, as well as a summary of testing sites.

Disponible en anglais seulement. Vous pouvez demander un version française.

Funded Biomarker Testing

2 items

Immunohistochemical evaluation, where indicated, to assess line of differentiation for classification

Funded Biomarker Disease Site: Soft Tissue

Biomarker:

Testing Method:Immunohistochemistry (IHC)

Testing Site: Hamilton Health Sciences, London Health Sciences Centre, Mount Sinai Hospital, St. Joseph's Healthcare Hamilton, The Ottawa Hospital

Reflex testing on newly diagnosed CD117 (cKIT) positive Gastrointestinal Stromal Tumours

Funded Biomarker Disease Site: Soft Tissue

Biomarker: BRAF, KIT, PDGFRA (Optional 23/24 - SDH, NTRK (fusion))

Testing Method:Sequencing

Testing Site: Hamilton Health Sciences, London Health Sciences Centre, Mount Sinai Hospital, St. Joseph's Healthcare Hamilton, Sunnybrook Health Sciences Centre, The Ottawa Hospital, University Health Network